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Abstract: The methanol extracts of the aerial part of four ethnomedicinal plants of Mediterranean
region, two non-seed vascular plants, Equisetum hyemale L. and Phyllitis scolopendrium (L.) Newman,
and two Spermatophyta, Juniperus communis L. (J. communis) and Cotinus coggygria Scop. (C. coggygria),
were screened against four human cells lines (A549, MCF7, TK6 and U937). Only the extracts
of J. communis and C. coggygria showed marked cytotoxic effects, affecting both cell morphology
and growth. A dose-dependent effect of these two extracts was also observed on the cell cycle
distribution. Incubation of all the cell lines in a medium containing J. communis extract determined
a remarkable accumulation of cells in the G2/M phase, whereas the C. coggygria extract induced
a significant increase in the percentage of G1 cells. The novelty of our findings stands on the
observation that the two extracts, consistently, elicited coherent effects on the cell cycle in four cell
lines, independently from their phenotype, as two of them have epithelial origin and grow adherent
and two are lymphoblastoid and grow in suspension. Even the expression profiles of several proteins
regulating cell cycle progression and cell death were affected by both extracts. LC-MS investigation
of methanol extract of C. coggygria led to the identification of twelve flavonoids (compounds 1–11,
19) and eight polyphenols derivatives (12–18, 20), while in J. communis extract, eight flavonoids
(21–28), a α-ionone glycoside (29) and a lignin (30) were found. Although many of these compounds
have interesting individual biological activities, their natural blends seem to exert specific effects on
the proliferation of cell lines either growing adherent or in suspension, suggesting potential use in
fighting cancer.
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1. Introduction
Many natural products have biological activity that can be of therapeutic benefit in treating
diseases [1]. Indeed, during the very last years, after the advent of molecular biology and combinatorial
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chemistry, natural products have partially lost their edges, assuming a secondary role in drug discovery
and drug development. However, more recent times have seen a rejuvenated and renewed interest for
natural compounds and their role as powerful basis for drug development. The reason to search for
pharmaceutically active plant extracts is very likely related to the co-evolution of plants and animals:
it is not surprising that plants have developed specific strategies aimed to defend themselves from
predation also producing substances able to interfere (negatively) with the animals physiology. Plant
extracts can act as potent muscle relaxants emetics, affect heart physiology, possess antimicrobial
properties, interfere with or hamper the cell cycle, and some are endowed of anticancer properties [2],
often displaying a synergistic action that increases their effects [3]. In this regard, in particular, the
knowledge of the cytological mechanisms involved in their actions seems of the utmost importance for
an eventual precise evaluation and development. This study originated from previous observations
made in this laboratory, searching for antimicrobial properties of plant extracts [4]. In that case, we
considered only extracts that resulted active against selected bacteria but were void of cytotoxicity. Now,
on the contrary, we have focused our attention on four extracts, two from non-seed vascular plants,
Equisetum hyemale L. (E. hyemale) and Phyllitis scolopendrium (L.) Newman (P. scolopendrium), and two
from Spermatophyta, Juniperus communis L. (J. communis) and Cotinus coggygria Scop (C. coggygria), that,
in turn, were characterized by some cytotoxicity. In this regard, we present new data on the biological
effect of these extracts. We demonstrate that the alcoholic extracts of C. coggygria and J. communis
possess interesting and reproducible properties that may merit further attention as they were able
to alter, each one with a specific effect, the cell cycle of four human cancer cell lines, independently
from the cells phenotype and origin. Two of them have epithelial origin (A549 and MCF-7, from lung
and breast adenocarcinomas) and two are lymphoblastoid (U936 and TK6). The two epithelial cells
grow adherent to the plate surfaces, while the two lymphoblastoid cells grow in suspension. Several
chemical analyses of the extracts from the active plants were performed allowing the isolation and
identification of several flavonoids and polyphenol derivatives.
2. Results and Discussion
We have studied the effects of several plant extracts on four human cell lines, namely MCF-7
(breast cancer), A549 (lung adenocarcinoma), U-937 (histiocytic lymphoma) and TK6 (human B
lymphoblastoid cells). The first two cell lines are anchorage-dependent, while the second two grow
in suspension. In order to evaluate the in vitro cytotoxic potential of the plant extracts, the effects
of different dilutions of each extracts were first analyzed by Trypan Blue exclusion assay, on the
adherent cell lines (data not shown). Analysis of these data allowed for the selection of the appropriate
dilution of the extracts. In addition, evident cellular effects (partial detachment, floating and changes
in morphology) were observed incubating MCF7 and A549 cells with extract from J. communis or
C. coggygria. These effects were much less pronounced, when cells were incubated with diluted extracts
from E. hyemale or P. scolopendrium. Hence, while focusing our attention on J. communis or C. coggygria,
we have used, when needed, the extracts from E. hyemale or P. scolopendrium, as controls.
2.1. Cell Viability and Growth
To measure the effects of extracts on cells viability and growth, MCF-7 was selected as an
illustrative example cell line. Cells were treated for 24 h with extracts #46 (J. communis) and #57
(C. coggygria), at 0.05%, 0.1%, and 0.15% v/v; the concentrations are expressed as percent v/v of the
saturated solutions at room temperature (i.e., a solution that contains the maximum concentration of
solutes. Additional solute will not dissolve in a saturated solution) as also reiterated in Section 3.2.
At the end of this incubation, Trypan blue solution was added and the cells were counted using a
hemocytometer. Data indicate that extracts affect cell viability in a dose-dependent manner. In addition,
it appears that extract #57 is more toxic to cells than extract #46 (Figure 1).
In order to evaluate if the observed cytotoxic effects were reversible or irreversible, MCF7 cells
were incubated for 24 h with the extracts, as described above, and the cells surviving the treatment
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were washed and released in fresh medium, and further analyzed 24 and 48 h later As shown in
Figures 2 and 3 the effect of extract #46 on cell proliferation was reversible, while that of extract #57
was irreversible at higher concentration.Molecules 2016, 21, 395 3 of 22 
 
Figure 1. Twenty-four hours of incubation with increasing amounts of extracts #46 and #57 arrest the 
growth of MCF-7 cells in a concentration dependent manner (p values: ** < 0.01; *** < 0.001). 
 
Figure 2. MCF-7 cells were treated for 24 h with 0 (controls), 5, 10 and 15 µL/mL of the extract #46, 
washed and counted. Two thousand cells from each incubation condition were seeded in a fresh 
medium-extract-free and counted again 24 and 48 h later (p values: * < 0.1; ** < 0.01). 
 
Figure 3. MCF-7 cells were treated for 24 h with 0 (controls), 5, 10 and 15 µL/mL of the extract #57, 
washed and counted. Two thousand cells from each incubation condition were seeded in a fresh 
medium-extract-free and counted again 24 and 48 h later (p values: * < 0.1; ** < 0.01; *** < 0.001). 
These data, on the whole, demonstrate that both J. communis and C. coggygria extracts affect cell 
viability in a dose- and time-dependent manner. The extract #57, in addition, when used at elevated 
concentration (≥15 µL/mL) induces an irreversible growth arrest and cell death. 
2.2. Effects of the Extracts on Cell Cycle 
We first studied the alterations in the cell cycle profile of A549 cells treated with the plant extracts 
for 24 h. We show data obtained with the highest life-compatible concentration explored (0.15% v/v). 
In such conditions, the cell cycle profiles displayed significant alterations. 
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Figure 2. MCF-7 cells were treated for 24 h with 0 (controls), 5, 10 and 15 µL/mL of the extract #46,
washed and counted. Two thousand cells from each incubation condition were seeded in a fresh
medium-extract-free and counted again 24 and 48 h later (p values: * < 0.1; ** < 0.01).
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viability in a dose- and time-dependent manner. The extract #57, in addition, when used at elevated
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2.2. Effects of the Extracts on Cell Cycle
We first studied the alterations in the cell cycle profile of A549 cells treated with the plant extracts
for 24 h. We show data obtained with the highest life-compatible concentration explored (0.15% v/v).
In such conditions, the cell cycle profiles displayed significant alterations.
When A549 cells were incubated with the extract #46 for 24 h, a significant number of cells
detached, while the others changed morphology assuming a rounded shape. Accordingly, cell cycle
analyses showed an accumulation of cells in the G2/M phase (from <8% in normal proliferating
cells to about 90% in extract #46-treated cells) (Figure 4, middle panel) This effect was reversible
as, replacing the cells media with fresh media (not containing the extracts), cells regain a normal
phenotype (morphology) and then appear to regain their grow potential.
In contrast, when the same cells were treated with extract #57 at low concentrations (i.e., 0.15%
(v/v), an accumulation of cells in G1 phase of cell cycle was observed (+20% as compared to controls),
associated with a reduction of cells in S phase (Figure 4, right panel). Even in this case, replacing the
media, the cells return cycling normally.
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gained with A549 cells when incubated with extract #46 (0.15%, v/v). Most of the cells accrual in the 
G2M phase, reaching 82% of the total. Considering that in control cells (Figure 5, left panel) the 
population in this phase does not exceed 30%, extract #46 induces an increase superior to 50% (Figure 5, 
middle panel). The addition of extract #57 to cell medium for 24 h induced a substantial increase in 
the percentage of resting cells (G0/G1), as the increase amounts to near 25% (Figure 5, right panel). 
 
Figure 5. Representative cell cycle profiles of untreated MCF-7 cells (controls, left), and cells incubated 
in media containing 0.15% (v/v) of extracts #46 (middle) and #57 (right). 
Overall, the cytometric data presented above refer principally to two different epithelial cancer 
lines that, although transformed are p53 positive and grow adhering to the surface of culture plates. 
Both sets of data, indeed, suggest that the extracts #46 and #57, individually, cause in the two cell 
lines similar and coherent effects. In particular, it appears that extract #46 arrests the cycle in the G2/M 
phase, while the extract #57 blocks the cells in the G1 phase. 
These observations prompted us to verify if the specific effects produced by the two extracts on 
adherent cells could be reproduced also on cells growing in suspension. Indeed, most of the data 
Figure 4. Representative cell cycle profiles of untreated 549 cells (controls, left), and cells incubated
in edia containing 0.15 (v/v) of extracts #46 ( iddle) and #57 (right).
As the MCF-7 cells are concerned, we obtained results quite completely superimposable to those
gained with A549 cells when incubated with extract #46 (0.15%, v/v). Most of the cells accrual in
the G2M phase, reaching 82% of the total. Considering that in control cells (Figure 5, left panel) the
population in this phase does not exceed 30%, extract #46 induces an increase superior to 50% (Figure 5,
middle panel). The addition of extract #57 to cell medium for 24 h induced a substantial increase in the
percentage of resting cells (G0/G1), as the increase amounts to near 25% (Figure 5, right panel).
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Overall, the cytometric data presented above refer principally to two different epithelial cancer
lines that, although transformed are p53 positive and grow adhering to the surface of culture plates.
Both sets of data, indeed, suggest that the extracts #46 and #57, individually, cause in the two cell lines
similar and coherent effects. In particular, it appears that extract #46 arrests the cycle in the G2/M
phase, while the extract #57 blocks the cells in the G1 phase.
These observations prompted us to verify if the specific effects produced by the two extracts on
adherent cells could be reproduced also on cells growing in suspension. Indeed, most of the data
obtained in this regard are concerned with the U937 cell line, but these findings are also supported by
some experiments on TK-6 cells (not shown).
Twenty-four hours of incubation of U937 cells in a medium containing 0.15% (v/v) of extract #46
determined a remarkable accumulation of cells in the G2/M phase. The percentage of cells populating
this phase in the controls amounted to about 5% of the total (Figure 6, left panel), while after the
incubation the same population was increased to more than 60% (Figure 6, middle panel).
The addition of extract #57 (0.15%, v/v) to cell medium for 24 h induced a visible increase in
the percentage of G0/G1 cells (compare the left and right panels of Figure 6). The addition of both
extracts #46 and #57, however, also causes the formation of debris (non-specific cell fragments and
possibly apoptosis).
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an ensemble of complex biological processes some of which have apparently opposing effects (repair,
tumor suppression/promotion, and aging).
For this reason, we were aimed to study the changes in the expression levels of a panel of these
proteins when cells were exposed to non-lethal doses of the extracts. Only a limited number of such
proteins, namely Cyclin B, Cdk1, Cdk2, p53, p21, p27, Caspase 9, Bcl-XL and Bcl-2, were actually
analyzed and principally (but not exclusively) in MCF-7 and A549 cells.
2.3.1. Cyclin B, Cdk 1
Cyclic B and Cdk1 are proteins involved in the cell cycle, generally acknowledged as pivotal
regulators of cell cycle during the transition from the G2 to M phase. Figure 7 illustrates the
electrophoretic expression profiles of Cyclin B and Cdk1 of MCF-7 cells exposed for 24 h to extract
#46 (0.15%, v/v). The clear augment of expression of both Cyclin B and CDK1 is in accord with the
experimentally observed arrest of cell cycle.
In the Figure 7A is also shown the expression profile of Cyclin B of MCF-7 cells exposed to extracts
#29 (E. hyemale) and #32 (P. scolopendrium) that do not alter the cell cycle of all cells studied and are
used as negative controls.
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Figure 7. The pictures illustrate the electrophoretic expression profiles of Cyclin B (A, MCF7 only) and
Cdk1 (B) of A549 and MCF-7 cells exposed for 24 h to extracts #46, #29 and #32 (0.15%, v/v). Both
panels indicate that this exposure increases the expression of Cyclic B and Cdk-1 proteins. Tubulin (B)
and actin (A) have been used as loading controls, respectively.
2.3.2. p53
The expression levels of the transcriptional factor p53 (Figure 8) have been analyzed in A549 and
MCF-7 incubated with extracts #46 and #57. It appears that the arrest in the G2/M phase induced by
extract #46 is accompanied by an increase in p53 expression in both A549 and MCF-7 cells. Differently,
extract #57 induces the expression of p53 exclusively in MCF-7 cells.
Molecules 2016, 21, 395 6 of 22 
electrophoretic expression profiles of Cyclin B and Cdk1 of MCF-7 cells exposed for 24 h to extract 
#46 (0.15%, v/v). The clear augment of expression of both Cyclin B and CDK1 is in accord with the 
experimentally observed arrest of cell cycle. 
In the Figure 7A is also shown the expression profile of Cyclin B of MCF-7 cells exposed to 
extracts #29 (E. hyemale) and #32 (P. scolopendrium) that do not alter the cell cycle of all cells studied 
and are used as negative controls. 
 
Figure 7. The pictures ill t t   l tr oretic expre sion profiles of Cyclin B (A, MCF7 only) 
and Cdk1 (B) of A549 and MCF-7 cells exposed for 24 h to extracts #46, #29 and   v). Both 
panels indicate that this ex s r    ression of Cyclic B and Cdk-1 proteins. Tubulin 
(B) and actin (A) have been used as loading controls, respectively. 
2.3.2. p53 
The expres ion levels of the transcriptional factor p53 (Figure 8) have be n analyzed in A549 and 
MCF-7 incubated with extracts #46 and #57. It ap ears that the ar est in the G2/M phase induced by 
extract #46 is accompanied by an increase in p53 expression in both A549 and MCF-7 cells. Differ ntly, 
extract #57 induces the expres ion of p53 exclusively in MCF-7 cells. 
 
Figure 8. Changes in the expression of p53 in A549 and MCF-7 cells induced by extracts #57 and #46. 
Extract #57 increases the expression of p53 exclusively in MCF-7 cells. Tubulin has been used as 
loading control. 
2.3.3. Cdk2, p21 and p27 
The protein Cdk2 is indispensable for the G1/S transition exerting its action through its 
association with specific regulatory cyclins. When required by specific conditions, Cdk2 function may 
be reduced or abolished by interacting with the protein p21, a specific inhibitor [7]. p27 might also 
play different roles in the cell cycle. Its over expression, for instance, regulates growth and differentiation, 
while moderate expression induces cell cycle arrest [7–10]. 
The expression of Cdk2 by A549 (Figure 9A, left) and MCF-7 cells (Figure 9, right) treated with 
extracts #46 and #57 changes as the electrophoretic doublet, present in controls, tends to fade following 
a decrease in the kinase activity. 
As p21 is concerned, we have analyzed its expression in both MCF-7 and A549 cells (Figure 9B). 
In this case, it appears that, compared to controls, p21 is strongly expressed in MCF-7 cells, while no 
evident changes have been observed in A549 cells. 
. Changes in th expression of p53 in A549 and MCF-7 cells induced by extracts #57 and
#46. Extract #57 increases the expressi n of p53 exclusively in MCF-7 cells. Tubulin has b en used
Molecules 2016, 21, 395 7 of 23
2.3.3. Cdk2, p21 and p27
The protein Cdk2 is indispensable for the G1/S transition exerting its action through its association
with specific regulatory cyclins. When required by specific conditions, Cdk2 function may be reduced
or abolished by interacting with the protein p21, a specific inhibitor [7]. p27 might also play different
roles in the cell cycle. Its over expression, for instance, regulates growth and differentiation, while
moderate expression induces cell cycle arrest [7–10].
The expression of Cdk2 by A549 (Figure 9A, left) and MCF-7 cells (Figure 9, right) treated with
extracts #46 and #57 changes as the electrophoretic doublet, present in controls, tends to fade following
a decrease in the kinase activity.
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Bcl-XL is a member of Bcl2 family proteins that is located within the mitochondrial membrane. 
Its pro-survival action is founded on its capacity to prevent Cytochrome C release and the associated 
caspases activation [11]. However, its expression level in both MCF-7 and A549 cells after 24 h of 
incubation with extracts #46 and #57 did not appear to sensibly change (Figure 10). 
  
Figure 9. (A) Changes in the expression of CDK2 in A549 and MCF-7 cells induced by extracts #57
and #46. The CDK2 doublet visible in the controls fades with the addition of both extracts indicating a
decline in the kinase activity. Tubulin has been used as loading control; (B) p21 expression in MCF-7
is induced by extracts #46 and #57. Tubulin has been used as loading control; (C) p27 expression
(after 24 h) in A549 and MCF-7 cells treated with extracts #46 and #57. p27 protein is significantly
induced by both extracts in A549 cells, but not in MCF-7 cells. Actin has been used as loading control.
As p21 is concerned, we have analyzed its expression in both MCF-7 and A549 cells (Figure 9B).
In this case, it appears that, compared to controls, p21 is strongly expressed in MCF-7 cells, while no
evident changes have been observed in A549 cells.
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Similarly we have analyzed the expression profiles of p27, a protein that may also block the cycle
progression at the level of the G1/S transition. Figure 9C depicts the expression of p27 in A549 and
MCF7 treated with extracts #46 and #57. It appears that A549 cells are more sensitive to extracts than
MCF-7 as A549 cells do not express appreciable basal levels of p27. On the contrary, the addition of
either extracts #46 or #57 (the latter in particular) results in substantial increase of expression levels of
this protein. This effect was not observed in MCF-7 cells, whose p27 basal level is already sustained.
Then, the addition of extract #57 does not cause any appreciable augment of p27 expression.
2.3.4. Bcl-XL
Bcl-XL is a member of Bcl2 family proteins that is located within the mitochondrial membrane.
Its pro-survival action is founded on its capacity to prevent Cytochrome C release and the associated
caspases activation [11]. However, its expression level in both MCF-7 and A549 cells after 24 h of
incubation with extracts #46 and #57 did not appear to sensibly change (Figure 10).Molec les 2016, 21, 395 8 of 22 
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on cell lines. Our observations are limited to changes in Bcl-2 expression and C spase 9 activation
in the MCF-7 cells only by extract #46. These data, while i dicating the abse ce of anti-apoptotic
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2.4. Evaluation of Senescence in Cells
The cell cycle arrest in G1 phase, determined by the action of some agents including chemotherapy
may induce in cells premature senescence [12] an ensemble of complex biological processes
characterized by cells specific morphological and biochemical changes. The effects produced by
the extract #57, which compels most cells into G1 phase, prompted us to verify if it would induce such
condition in A549 cells that are prone to become senescent in stressing condition. To this purpose,
A549 cells were incubated for six days in the presence of 5 µL/mL of extract #57 of medium (every two
days, the medium was replaced with fresh medium containing the same amount of extract). Cells were
then incubated for additional 72 h with fresh medium without the extract. At the end of this treatment,
cells were analyzed for morphological changes (Figure 11) and for the acquired capacity to express
SA-β-galactosidase activity (Figure 12), through the appearance of the characteristic green-blue spots
in the cytoplasm.
This finding indicates that the extract #57 at a non-lethal concentration promotes specific G1
accumulation and induce premature senescence, a characteristic effects associated to anticancer drugs
when used at low concentrations (doxorubicin, for example).
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2.5. DPPH-Based Assay to Esti ate the ntioxidant apacity of J. co is a . c ri t t
The alcoholic extracts of the aerial parts of J. co unis and . coggygria plants ere tested for
their scavenging e fects to ar s 2,2- iphenyl-1-picrylhydrazyl ( PP ) radical. e have found that
J. co is f a good antiradical activity, as it is able to scavenge the DPPH‚ by
57. % ˘ 2.3% at dose of 100. µg/mL. At the same concentra ion, C. coggy ria extract was much less
powerful as its scavenging capacity was about 50% of that of extract from J. communis.
2.6. Identification and Characterization of Che ical Co ponents of the Plant Extracts
The last aspect that e have considered as the identification of the ajor natural co ponents of
the plant extracts. The Table 1 su marizes the array of phenolic compounds that we have identified
in methanolic extracts of C. coggygria and J. co munis by liquid chromatography–mass spectro etry
(LC- S) detection. In particular, LC-MS investigation of methanol extract of C. coggygria led to the
identification of flavonoids 1–11 and 19 and polyphenols derivatives 12–18 and 20, hile in J. co unis
ethanol extract the flavonoids 21–28, the α-ionone glycoside 29 and the lignin 30 ere found. ll
isolated co pounds ere identified for co parison ith the data reported in the literature and in the
database of the instru ent. Their chemical structures are shown in Figures 1 and 2 hereas the
I P na es are indicated in Tables 1 and 2 of the ppendix .
Most of them certainly hold biological properties that may interfere with cell proliferation as
suggested by Kuntz et al [13]. F r instance, as far as flavo oids are concerned, fisetin, sulfuretin,
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isoliquiritigenin, quercetin, apigetrin, and amentoflavone [14–20] have all been considered active
against breast cancer cells acting at various levels.
Table 1. Major components from C. coggygria and J. communis extracts.
Ethyl Acetate Extracts Water Extracts
C. coggygria J. communis C. coggygria J. communis
Liquiritigenin (1) Amentoflavone (27) Rutin (10) Catechin (21)
Fustin (2) Cupressoflavon (28) Gallic acid (12) Apigenin (22)
Naringenin (3) Corchoionoside C (29) Coumaric acid (13) Quercetin (23)
Taxifolin (4) Matairesinol (30) Caffeic acid (14) Isoquercetin (24)
Isoliquiritigenin (5) Ferulic acid (15) Apigetrin (23)
Butein (6) Rosmarinic acid (16) Kaempferol-7-O-α-D-Glucopiranoside (26)
Fisetin (7) Chlorogenic acid (17)
Eriodictyol (8) Resveratrol (18)
Myricetin (9) Pentagalloyl glucose (20)
Kaempferol (11)
Sulfuretin (19)
Similarly, polyphenol derivatives isolated from C. coggygria and J. communis have shown cytotoxic
activity against several cancer cell lines: caffeic, coumaric and ferulic acids can act against lung and
colon cancer cell line growth, controlling adhesion and migration steps of tumor progression [21], and
penta-O-galloylglucose [22], inhibit the proliferation of human breast cancer cells. The anti-proliferative
action is not limited to simple phenolics: also the lignan matairesinol evidenced a cytostatic activity
against breast and colon cancers [23].
Polyphenols derivatives may cause cell cycle arrest and induce apoptosis; resveratrol was shown
to activate p53 by phosphorylation, and significantly increases the pro-apoptotic signals such as
Bak and p21 genes [24,25], whereas Gallic acid stimulated the synthesis of Bax and Bad protein and
induced a decrease of Bcl-2 and Bcl-xL levels in NCI-H460 lung cancer cells [26]. But also flavonoids
as quercetin affect the cell cycle of different cancer cell lines, inhibiting the activity of CDK2 [27],
activating caspases and downregulating the expression of anti-apoptotic Bcl-2 and tumor suppressing
p53 proteins [28]. In the same way, apigenin and kampferol can induce a strong down-regulation of
CDK1 and a relatively small up-regulation of p27 [29]. Both extracts that we studied possess mild to
weak antioxidant properties. This may result by the concomitant presence of several natural substances
whose individual characteristics may differ from those of the blend that we find in the extract. Natural
products, and particularly those possessing considerable variation of phenolic composition certainly
have a steric complexity larger than any synthetic drugs [30]. This implies that plant crude extracts
may present unpredictable therapeutic effects that are different, in type and intensity, from those
exhibited by individual components [31].
Undoubtedly, the extracts own attractive and unique properties that may find interesting
applications for in vitro studies and even as potential drugs. This, however, deserves further attention
and requires more targeted studies.
3. Materials and Methods
3.1. Collection of Plant Samples
C. coggygria, E. hyemale, J. communis and P. scolopendrium plants were collected during spring and
summer of 2014 in the regional parks of Matese and Cilento, Campania, Southern Italy, by scientists
from the Dipartimento delle Scienze Biologiche of the University Federico II of Naples. Shortly
after collection, plant materials (branches and leaves) were air-dried, cut to slices and finely crushed.
The resulting powder-like materials were stored at ´20 ˝C. Voucher specimens have been deposited in
the Herbarium of the Botanical Garden of the “Federico II” University in Naples, Italy.
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3.2. Preparation of Plant Extract
Exactly 4 g of each powdered plant materials (i.e. from the above 4 plants) were all extracted
with the same procedure as previously described [4]. In brief, extraction procedure was carried out
at room temperature (~25 ˝C) in 100 mL Erlenmeyer flasks. Suspensions were kept in ultrasonic
baths for 30 min, followed by 24 h continuous stirring (90 rpm) in a rotary shaker. Extracts were
then filtered on paper (Whatman, n.1) and concentrated using a vacuum roto-evaporator at 38 ˝C.
The dried material was finally weighted and dispersed in 1 mL of 10% aqueous dimethylsulfoxide
(DMSO). The suspensions, kept at 37 ˝C overnight under gentle stirring, were finally centrifuged in a
microfuge for 5 minutes. Centrifuged samples showed a substantial solid separated phase (insoluble
residue) at the bottom overlaid with a transparent solution. These intensely colored (from deep green
to orange/brown) saturated solutions were considered the “stock solutions” and stored at 4 ˝C in the
dark. Before each use, stock solutions were brought to room temperature under continuous shaking
to resuspend the solid material present at the bottom of the tubes. These suspensions were then
transferred into Eppendorf tubes and microfuged extensively. Small amounts of liquids were collected
from the surface of the clear solutions and finally diluted 1:10 with 2% DMSO. The final concentrations
(expressed in percent v/v) of plant extracts in the medium of cells in the various experiments were of
0.005, 0.01 and 0.015 volumes of original “stock saturated solutions” for 100 volumes of cells culture
media. In all experiments, the final DMSO concentration was always ď1% v/v.
No special precautions were taken in handling stock solutions of extracts as their properties
remained intact for longer than six months (in closed Eppendorf tubes, the dark at 4 ˝C). The extracts
high concentrations, the high concentration of DMSO (which is characterized by intrinsic strong
antioxidant properties), the small amount of air in contact with the solution surfaces within the small
containers, and the rapid handling of samples all concurred to prevent or minimize oxidation.
3.3. General Composition of Plant Extracts
A detailed description of procedures used to isolate and identify the major natural components
from plant extracts indicated below, is reported detailed in details in the Supplementary Materials
Section of this work.
3.4. Microbiological Assay
Although extraction procedures were conducted with care and required a long stay of plants
remnants in alcohol, sterility was not fully guaranteed. For this reason we performed a series of
microbiological assays to test the presence of bacterial or mold contaminants in the various extracts.
To this purpose we added 15 µL of each stock (very concentrated solutions) to plates (60 mm) containing
1 mL DMEM (control) or 1 mL DMEM containing 1 µL penicillin (100 µg/mL), 1 µL Streptomicin
(100 µg/mL) and 1 µL Anfotericin B (2.5 µg/mL). Plates were incubated up to 72 h at 37 ˝C. Extracts
from J. communis were found to be sterile, while a slight contamination was found in extracts from
E. hyemale, P. scolopendrium (after 72 h of incubation) and C. coggygria (after 24 h of incubation). We then
proceeded to identification of bacterial contaminants that were as indicated in Table 2.
Table 2. Bacterial strains in extracts.
Extracts (Undiluted Stocks) 15 µL Incubation Time (h) (in DMEM) Bacterial Strain
J. communis 72 Sterile
C. coggygria 24
B. licheniformis
B. subtilis
B. sonorensis
P. scolopendrium 72 B. licheniformisB. subtilis
E. hyemale 72 B. licheniformisB. subtilis
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The same amounts of extracts in the presence of antibiotics, as indicated above, showed full
absence of bacterial growth.
3.5. Cell Lines
The cell lines used in this work are four, two having epithelial origin as the MCF-7 (human breast
cancer) and the A549 (human lung adenocarcinoma and two lymphoblastoid lines, namely the U-937
(histiocytic lymphoma) and TK6 cells. The latter line, however, has been used only in limited sets
of experiments. All cell lines have been obtained from ATCC (Rockville, MD, USA) and cultured
according to its instructions. In brief, the two epithelial cell lines MCF7 and A549 cells have been
cultured at 37 ˝C with 5% CO2 in 100 mm plates in Dulbecco’s Modified Eagle Medium (DMEM, Sigma,
Milan, Italy) containing 20 mM Glycine. The U937 and TK6 cells, which grow in suspension, have been
cultured in flasks in RPMI 1640–Glutamine. All media were supplemented with 10% FCS. At 70%–80%
confluence, cells were detached by plates by trypsinization (MCF7 and A549) or centrifuged for 5 min
at 1200 RPM (U937 and TK6) and re-plated or resuspended in fresh medium according to the needs.
All cell media contained 1% penicillin/streptomycin/anfotericin.
3.6. Cells Growth and Viability Assay
Cells were plated in triplicate at 2 ˆ 104 per well in a 96-well plates. After 16 h, extracts were
added to cells in the medium at 3 different concentrations, namely 0.05%, 0.1% and 0.15% (v/v).
The final DMSO concentration in these cells was always set at <1%. Cell number was assessed using a
hemocytometer. Trypan blue (0.08%; Sigma) was added to evaluate cell viability.
3.7. Flow Cytometry
Flow cytometric analysis was as described before [32]. In brief, about 1.5 ˆ 105 cells were
harvested, fixed in 70% cold ethanol and stored at 4 ˝C overnight. Before analysis, cells were washed
in distilled water, centrifuged and resuspended in 1 mL PBS containing propidium iodide (50 µg/mL,
Sigma) and RNase-DNase-free (100 µg/mL, Roche, Milan, Italy), for DNA staining. After 1 h in the
incubator at 37 ˝C, samples were kept in the dark for 20 min at room temperature before final readings.
Fluorescence was detected using the 488 nm laser line with a CyAn ADP Flow Cytometer (DAKO
Cytomation). About 20,000 events (ě15,000 cells) were recorded for each sample (in triplicate). Cell
cycle profiles were analyzed using ModFit/LT 3.2 version (Verity Software, Topsham, ME, USA).
Typical profiles (selected among two or three independent experiments) are reported in Figures 4–6.
3.8. Western Blot Analysis
Total cell proteins preparations were obtained lysing an adequate number of cells by 1 mmol/L
EDTA, 0.2% Triton X-100, 1 µg/mL aprotinin, 170 µg/mL phenylmethylsulfonyl fluoride, and
phosphatase inhibitors (Sigma). Protein concentration was routinely measured by the Bio-Rad protein
assay (Milan, Italy) [33]. Polyacrylamide gels (7.5%–15%) were prepared essentially as described by
Laemmli [34]. Molecular weight standards were from New England Biolabs (Hitchin, Herts, UK).
Proteins separated on the polyacrylamide gels were blotted onto nitrocellulose filters (Hybond-C,
Amersham, Milan, Italy). Filters were washed and stained with specific primary antibodies and then
with secondary antisera conjugated with horseradish peroxidase diluted (1:2000; Bio-Rad). Filters were
developed using the enhanced chemiluminescence Western blotting detection reagent (Amersham).
Typical electrophoretic patterns (selected among two or three independent experiments) are reported
in Figures 7–10.
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3.9. Antibodies
Anti-Bcl-2 (100), -p27KIP1 (C-19), -p21CIP1 (C-19), -Cdk2 (M2), -Cdk1, -p53 (DO-1), and -caspase-9
and all secondary antibodies were purchased from Santa Cruz Biotechnology; anti-tubulin antibodies
were from Serotec (Oxford, UK).
3.10. Senescence-Associated β-galactosidase Activity
Staining for SA-β-galactosidase activity was done on cells previously fixed in 3%
formaldehyde-cell medium 10% FBS solution. After extensive washing, fixed cells were treated
at 37 ˝C for 24 h with a staining solution as previously described [35]. To this purpose, cells were
plated in triplicate at 5 ˆ 104 in 35-mm dishes. Adherent, SA-β-galactosidase-positive cells were
searched in random fields using bright field microscopy.
3.11. Statistical Analysis
All tests described therein have made use of the free statistical package GraphPad [36].
Significance was assessed using Student’s t test for comparison between two means (p values: * < 0.1;
** < 0.01; *** < 0.001).
3.12. Chemicals
Column chromatography (CC) was carried out on Merck Kieselgel 60 (230´400 mesh). Electronic
Impact Mass Spectra (EI-MS) were obtained with a QP-5050A (Shimadzu) EI 70 eV spectrometer. Anal.
TLC: Kieselgel 60 F254 plates (0.2-mm; Merck, Darmstadt, Germany); visualization under UV light
and by spraying with H2SO4/AcOH/H2O 1:20:4, followed by heating for 5 min at 110 ˝C. Liquid
chromatography (LC) analysis was carried out using UFLC prominence series (Shimadzu Corp., Kyoto,
Japan), equipped with a vacuum degasser, a quaternary pump, an autosampler, a column heater and
PDA detector (diode array detector, DAD). Separation was accomplished using a Phenomenex Luna
C18 column (Phenomenex, Italy) (5.0 µm, 2.0 cm ˆ 30 cm).
3.13. Extraction and Isolation Procedures
C. coggygria: Dried branches and leaves were air-dried and pulverized. The powder (126 g) was
extracted with methanol (3 ˆ 500 mL) for 48 h by maceration. The resultant extracts were combined,
filtered and concentrated to dryness in vacuo at 40 ˝C. The resulting extract (6.2 g) was then suspended
in water and partitioned with ethyl acetate to give, upon drying, an ethyl acetate-soluble residue (1.9 g
first collection; 0.5 g second collection) and water. The organic fraction was fractionated into acidic
and neutral fractions with aqueous 2 N NaOH solution. The neutral solution was washed with water
and concentrated in vacuo (0.52 g), while the aqueous solution was first acidified with aqueous 2 N
HCl to neutral pH and then extracted with ethyl acetate, according to Scheme 1 (see also Figure A3).
The neutral fraction was subjected to silica gel column chromatography using a gradient solvent
system (CH2Cl2/acetone = 100:0–95:5–90:10–80:20–70:30–50:50) to give 18 fractions. The fractions
cleaner on TLC (Nf1, Nf3, Nf5, and Nf6) were injected to HPLC-MS. Compounds 1, 3, 4, and 7 were
identified from the fraction Nf1, compounds 2 and 8 from the fraction Nf3, compounds 5, 6, and 9
from the fraction Nf5 and, finally, compounds 11 and 19 from the fraction Nf6. A volume equal to
one-tenth of water was lyophilized (320 mg) and filtered on Sep-Pak C18, eluting with water, methanol
and acetonitrile. The first two fractions were analyzed by LC-MS and compounds 12–15 and 20 were
identified from the water fraction and compounds 10, 16–18 were identified from the methanol fraction
(Figure A1, Table A1). For comparison with the data reported in the literature and in the database of
the detector, all isolated compounds (1–20) were identified (Table A3).
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(NfA-NfN). The fractions were directly analyzed by HPLC-MS. Compounds 27 and 28 were identified
from the fraction NfC, compounds 29 and 30 from the fraction NfD. A volume equal to one-tenth
of water was lyophilized (312 mg) and filtered on Sep-Pak C18, eluting with water, methanol and
acetonitrile. The first two fractions were analyzed by LC-MS and compounds 24–26 were identified
from the water fraction (WW1) and compounds 21–23 were identified from the methanol fraction
(WM1) (Figure A2, Table A2). For comparison with the data reported in the literature and in the
database of the detector, all isolated compounds (21–30) were identified (Table A4).
3.14. Determination of 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Radical Scavenging Capacity
Alcoholic extracts of J. communis and C. coggygria were evaluated at different concentration levels.
Tests have been carried out performing three replicate measurements on three samples (n = 3) of each
extract. Results are expressed as the mean ˘ SD values. In order to estimate the DPPH‚ scavenging
capability, the extracts at various final concentrations (namely 0.625, 1.25, 2.5, 5.0, 12.5, 25.0, 50.0 and
100.0 µg/mL) were dissolved in a DPPH‚ ethanol solution (9.4ˆ 10´5 M; 1.0 mL) at room temperature.
After 30 min, the absorption at 517 nm was measured by a Jasco UV-Vis V560 spectrophotometer in
reference to a blank. The results were expressed in terms of the percentage decrease of the initial DPPH
radical absorption by the test samples.
3.15. LC-MS/MS Analysis
About 1 mg of Nf1, Nf3, Nf5, Nf6, NfC, NfD, WW, WM, WW1 and WM1 fractions were
dissolved in 0.8 mL MeOH filtered through a 0.45 mm filter and subjected to high performance
liquid chromatography (HPLC). For qualitative analysis, the Shimadzu (Milano, Italy) LCMS-8040
Triple Quadrupole Liquid Chromatograph Mass Spectrometer (LC-MS/MS) was used. Separations
were accomplished on Phenomenex Luna C18 column (100 mm ˆ 2.1 mm, 1.6 µm) at a flow rate
of 0.25 mL/min with water (solvent A) and acetonitrile (solvent B containing 0.1% formic acid) as
mobile phase, and the gradient elution program was as follow: 15%–100% B over 10 min, followed
by isocratic elution with 100% solvent (B) from 10–20 min, then returned to 15% from 22 min at
a flow rate of 0.8 mL/min. The column temperature was maintained at 45 ˝C and the injection
volume was 10 µL. Separation of compounds was monitored with DAD at 254 and 190 nm and
with a mass spectrometry detector. Mass spectrometric analysis (ESI) was carried out on LC-MS 8030
triple-quadrupole mass spectrometer (Shimadzu, Kyoto, Japan). Liquid chromatography–tandem mass
spectrometry (LC-MS/MS) was set in the negative and positive ionization mode with spectra acquired
over a mass range of 50–1000 m/z. The acquisition parameters were as follows: interface voltage,
4.5 kV; interface temperature, 230 ˝C; desolvation line temperature, 230 ˝C; heat block temperature,
350 ˝C; desolvation gas, nitrogen; desolvation gas flow rate, 3.5 L/min; drying gas, nitrogen; drying
gas flow rate, 20 L/min; collision gas, argon; dwell time, 20 ms; and collision gas pressure, 240 kPa.
The most appropriate precursor ion, daughter ion, cone volt-age, collision energy (CE) were adjusted
according to each analyte.
4. Conclusions
The present findings confirm that the natural blend of compounds in the alcoholic extracts from
J. communis and C. coggygria, have cell cycle specific inhibitory properties that can be conveniently used
for in vitro studies and encourage efforts for in vivo assessments for their potential targeted applications
in cancer therapy.
Supplementary Materials: Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/
21/4/395/s1.
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Table A1. Compounds 1–20 identified by methanol extract of C. coggygria.
No. Common Name IUPAC Name CAS Number Ref.
1 Liquiritigenin 4’,7-Dihydroxyflavanone 578-86-9 [37]
2 Fustin 3’,4’,7-Trihydroxyflavanol 20725-03-5 [38]
3 (R,S)-Naringenin 4’,5,7-Trihydroxyflavanone 67604-48-2 [39,40]
4 Taxifolin 3’,4’,5,7-Tetrahydroxyflavanol 480-18-2 [40]
5 Isoliquiritigenin trans-2’,4,4’-Trihydroxychalcone 961-29-5 [41]
6 Butein trans-2’,3,4,4’-Tetrahydroxychalcone 487-52-5 [38]
7 Fisetin 3’,4’,7-Trihydroxyflavonol 528-48-3 [39]
8 Eriodictyol 3’,4’,5,7-Tetrahydroxyflavonol 4049-38-1 [39]
9 Myricetin 3,5,7,3’,4',5’-Hexahydroxyflavone 529-44-2 [37]
10 Rutin Quercetin 3-O-α-L-rhamnopyranosyl-(1Ñ6)-β-D-glucopyranoside 153-18-4 [37]
11 Kaempferol 3,5,7,4’-Tetrahydroxyflavone 520-18-3 [42]
12 Gallic acid 3,4,5-Trihydroxybenzoic acid 149-91-7 [40]
13 Coumaric acid 4-Hydroxycinnamic acid 25429-38-3 [37]
14 Caffeic acid 3,4-Dihydroxycinnamic acid 331-39-5 [37]
15 Ferulic acid 3-Methoxy-4-Hydroxycinnamic acid 1135-24-6 [37]
16 Rosmarinic acid (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid 20283-92-5 [43]
17 Chlorogenic acid 3-O-Caffeoylquinic acid 327-97-9 [37]
18 Resveratrol 3,4’,5-Trihydroxystilbene 501-36-0 [44]
19 Sulfuretin 3’,4’,6-Trihydroxyaurone 50-99-7 [38]
20 Pentagalloyl glucose 1,2,3,4,6-Pentagalloyl-D-glucose 50678-27-8 [37]
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Table A2. Compounds 21–30 identified by methanol extract of J. communis.
No. Common Name IUPAC Name CAS Number Ref.
21 Catechin 3’,4’,5,7-Tetrahydroxy-2,3-trans-flavan-3-ol 154-23-4 [45]
22 Apigenin 5,7,4’-Trihydroxyflavone 520-36-5 [46]
23 Quercetin 3,5,7,3’,4’-Pentahydroxyflavone 117-39-5 [37]
24 Isoquercetin 3-O-β-D-Glucopyranosylquercetin 482-35-9 [37]
25 Apigetrin Apigenin 7-O-β-D-Glucopiranoside 578-74-5 [46]
26 - Kaempferol-7-O-β-D-Glucopiranoside 16290-07-6 [47]
27 Amentoflavone Didemethyl ginkgetin 1617-53-4 [48]
28 Cupressoflavon - - [48]
29 Corchoionoside C (6S,9S)-Roseoside A 185414-25-9 [49]
30 Matairesinol Dibenzylbutyrolactone lignanolide 580-72-3 [50]
Table A3. LC-MS product ions Compounds 1–20.
Compound Precursor Ion (m/z) Daughter Ion (m/z) Ref.
1 255 [M ´ H]´ 135 [37]
2 271 [M ´ H]´ - [38], standard
3 271 [M ´ H]´ 177, 151, 119, 107 [39,40], standard
4 303 [M ´ H]´ 285, 251, 235, 217, 179, 177, 125, 113, 101 [40]
5 279 [M + Na]+ - [41]
6 271 [M ´ H]´ - [38]
7 285 [M ´ H]´ 257, 241, 229, 163, 135, [39]
8 287 [M ´ H]´ 151, 135, 125, 107 [39]
9 317 [M ´ H]´ 271, 245, 179, 152, 151, 137, 124 [40]
10 609 [M ´ H]´ 301, 300 [37]
11 285 [M ´ H]´ 257, 229, 213 [42]
12 169 [M ´ H]´ 125, 127, 107 [40]
13 163 [M ´ H]´ 119 [37]
14 179 [M ´ H]´ 135, 117 [37]
15 193 [M ´ H]´ 178, 149, 134 [37]
16 359 [M ´ H]´ 197, 160 [43]
17 353 [M ´ H]´ 191, 179, 173, 161, 135 [37]
18 227 [M ´ H]´ 185, 159, 158, 143, 119, [44]
19 269 [M ´ H]´ - [38]
20 939 [M ´ H]´ 787, 769, 617 [37]
Table A4. LC-MS product ions compounds 21–30.
Compound Precursor Ion (m/z) Daughter Ion (m/z) Ref.
21 289 248, 227, 217, 203, 188, 164, 151, 125,123 [45]
22 269 227, 195, 183, 151, 121, 117, 107 [46]
23 301 273, 229, 178, 151 [37]
24 463 300, 301, 303 [37]
25 431 269, 225, 197, 183, 169, 151, 121, 117 [46]
26 447 285, 254 [47]
27 537 [48], standard
28 537 - [48], standard
29 385 [49]
30 357 342, 313, 298, 209 [50]
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